Human Retinas React to Light 10 Hours Postmortem in Breakthrough Study

In a groundbreaking study, researchers have successfully maintained the function of human retinas outside the body for up to 10 hours postmortem, doubling previous records. This advancement is seen as a crucial step toward the possibility of whole-eye transplants that could restore vision.

Extending Retinal Functionality After Death

The research, led by Eimear Byrne at the Barcelona Institute of Science and Technology, utilized an innovative system to perfuse donor eyes with an oxygen-rich solution. This approach preserved the retinas' ability to respond to light, maintaining their health for 24 hours after death. The technique involved inserting a flexible tube into the ophthalmic artery, which supplies blood to the eye, and using a custom-built device called the Eye-in-Care-Box to regulate pressure and flow automatically.

By perfusing one eye from each of six donors while leaving the other untreated, the researchers demonstrated that the perfusion system significantly delayed retinal degradation. Further tests on 36 additional donor eyes showed that 15 of them retained electrical responses to light, akin to those in living individuals. These responses persisted for up to 10 hours after death.

Challenges and Future Implications

Despite this success, challenges remain in the field of eye transplantation. One significant hurdle is the regeneration of the optic nerve fibers, which are severed during eye removal. Without these fibers connecting to the brain's visual centers, a transplanted eye cannot transmit visual information. Thomas Johnson from Johns Hopkins University, though not involved in the study, emphasized the need for solutions that promote optic nerve regrowth.

While this research does not solve the issue of optic nerve regeneration, it provides a critical foundation for future strategies aimed at restoring vision. By maintaining the metabolic health of donor eyes, the Eye-in-Care-Box could facilitate more effective vision-restoration techniques and reduce damage from ischemia.

Broader Applications for Eye Research

Beyond transplantation, the Eye-in-Care-Box holds potential for testing vision-related therapies directly on human eyes. Byrne's team suggests that this technology could lead to the development of new in-vitro models and experimental paradigms for drug testing and understanding eye diseases. Johnson concurs, highlighting the advantage of applying results more directly to human conditions.

This study, published on the preprint server bioRxiv, marks a significant milestone in the quest to restore sight through medical innovation. As researchers continue to explore the complexities of the human eye, this breakthrough offers hope for millions affected by vision loss worldwide.